Daniel Irimia, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 70 | 2024 | 3785 | 9.900 |
Why?
|
| Microfluidic Analytical Techniques | 52 | 2021 | 823 | 7.430 |
Why?
|
| Chemotaxis | 22 | 2023 | 600 | 5.650 |
Why?
|
| Microfluidics | 35 | 2023 | 674 | 5.560 |
Why?
|
| Chemotaxis, Leukocyte | 19 | 2023 | 660 | 4.060 |
Why?
|
| Cell Movement | 38 | 2024 | 5216 | 3.620 |
Why?
|
| Chemotactic Factors | 10 | 2024 | 197 | 2.920 |
Why?
|
| Burns | 12 | 2025 | 1901 | 2.310 |
Why?
|
| Lab-On-A-Chip Devices | 7 | 2023 | 446 | 1.910 |
Why?
|
| Candida albicans | 7 | 2024 | 375 | 1.810 |
Why?
|
| Docosahexaenoic Acids | 8 | 2025 | 914 | 1.790 |
Why?
|
| Aspergillus fumigatus | 4 | 2024 | 158 | 1.740 |
Why?
|
| Sepsis | 9 | 2025 | 2609 | 1.710 |
Why?
|
| Leukocytes | 8 | 2019 | 2034 | 1.350 |
Why?
|
| Monocytes | 5 | 2025 | 2603 | 1.220 |
Why?
|
| Spheroids, Cellular | 2 | 2021 | 331 | 1.190 |
Why?
|
| Megakaryocytes | 2 | 2023 | 571 | 1.120 |
Why?
|
| Aspergillosis | 3 | 2024 | 242 | 1.090 |
Why?
|
| Microinjections | 2 | 2017 | 323 | 1.080 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 5 | 2018 | 221 | 1.020 |
Why?
|
| Staphylococcus aureus | 4 | 2022 | 1430 | 0.920 |
Why?
|
| Antifungal Agents | 3 | 2024 | 761 | 0.900 |
Why?
|
| Blood | 3 | 2019 | 597 | 0.850 |
Why?
|
| tau Proteins | 5 | 2021 | 2145 | 0.810 |
Why?
|
| Complement C5a | 3 | 2021 | 100 | 0.800 |
Why?
|
| Candidiasis | 5 | 2024 | 367 | 0.790 |
Why?
|
| Hyphae | 3 | 2021 | 52 | 0.790 |
Why?
|
| Nipecotic Acids | 1 | 2021 | 36 | 0.770 |
Why?
|
| Complement Inactivating Agents | 1 | 2021 | 53 | 0.770 |
Why?
|
| Interleukin-8 | 4 | 2018 | 705 | 0.750 |
Why?
|
| Actinomyces | 1 | 2021 | 41 | 0.740 |
Why?
|
| Antibiosis | 1 | 2021 | 46 | 0.720 |
Why?
|
| Glutamine | 1 | 2023 | 578 | 0.720 |
Why?
|
| Streptococcus | 1 | 2021 | 198 | 0.710 |
Why?
|
| Neutrophil Infiltration | 3 | 2024 | 395 | 0.700 |
Why?
|
| Host-Pathogen Interactions | 2 | 2020 | 1469 | 0.700 |
Why?
|
| Leukocyte Disorders | 2 | 2022 | 12 | 0.700 |
Why?
|
| Cell Separation | 9 | 2016 | 1728 | 0.690 |
Why?
|
| Blood Platelets | 3 | 2023 | 2479 | 0.670 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2021 | 251 | 0.670 |
Why?
|
| Phagocytosis | 10 | 2024 | 1530 | 0.670 |
Why?
|
| Deoxyribonucleases | 2 | 2018 | 209 | 0.670 |
Why?
|
| Complement Activation | 1 | 2021 | 447 | 0.670 |
Why?
|
| Fungi | 2 | 2021 | 345 | 0.660 |
Why?
|
| High-Throughput Screening Assays | 4 | 2018 | 941 | 0.650 |
Why?
|
| Borrelia burgdorferi | 1 | 2021 | 183 | 0.650 |
Why?
|
| Zebrafish | 5 | 2019 | 3037 | 0.640 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 551 | 0.640 |
Why?
|
| Models, Biological | 8 | 2020 | 9499 | 0.610 |
Why?
|
| Cell Communication | 6 | 2020 | 1660 | 0.600 |
Why?
|
| Colloids | 1 | 2018 | 126 | 0.600 |
Why?
|
| Tretinoin | 1 | 2021 | 525 | 0.580 |
Why?
|
| Inflammation | 17 | 2022 | 10869 | 0.580 |
Why?
|
| Dictyostelium | 2 | 2017 | 70 | 0.550 |
Why?
|
| Amyloid beta-Peptides | 6 | 2021 | 3912 | 0.540 |
Why?
|
| Time-Lapse Imaging | 4 | 2020 | 194 | 0.540 |
Why?
|
| Hepatic Insufficiency | 1 | 2016 | 14 | 0.530 |
Why?
|
| Cell Migration Assays, Leukocyte | 1 | 2016 | 8 | 0.530 |
Why?
|
| Alzheimer Disease | 10 | 2023 | 8758 | 0.530 |
Why?
|
| Biofilms | 1 | 2021 | 634 | 0.520 |
Why?
|
| Aniline Compounds | 1 | 2021 | 1094 | 0.520 |
Why?
|
| Streptavidin | 1 | 2015 | 81 | 0.510 |
Why?
|
| Humans | 136 | 2025 | 768887 | 0.510 |
Why?
|
| Biological Assay | 2 | 2018 | 628 | 0.510 |
Why?
|
| Rats, Wistar | 5 | 2018 | 1890 | 0.500 |
Why?
|
| HL-60 Cells | 6 | 2021 | 364 | 0.500 |
Why?
|
| Cytoplasm | 1 | 2020 | 1505 | 0.490 |
Why?
|
| Lyme Disease | 1 | 2021 | 630 | 0.480 |
Why?
|
| Biotin | 1 | 2015 | 256 | 0.470 |
Why?
|
| Organoids | 2 | 2018 | 745 | 0.470 |
Why?
|
| Cells, Cultured | 17 | 2021 | 19023 | 0.460 |
Why?
|
| Dystonia Musculorum Deformans | 2 | 2014 | 158 | 0.460 |
Why?
|
| Equipment Design | 12 | 2018 | 3529 | 0.440 |
Why?
|
| Erythrocytes | 8 | 2023 | 2421 | 0.420 |
Why?
|
| Models, Immunological | 1 | 2015 | 518 | 0.420 |
Why?
|
| Microchemistry | 3 | 2008 | 55 | 0.410 |
Why?
|
| Immune System | 1 | 2018 | 800 | 0.410 |
Why?
|
| Capillaries | 1 | 2016 | 756 | 0.410 |
Why?
|
| Cytoskeleton | 7 | 2019 | 1180 | 0.400 |
Why?
|
| Cryopreservation | 4 | 2011 | 733 | 0.400 |
Why?
|
| Immune System Diseases | 1 | 2014 | 253 | 0.400 |
Why?
|
| Blood Chemical Analysis | 2 | 2016 | 436 | 0.390 |
Why?
|
| Interleukin-1 | 1 | 2015 | 1251 | 0.380 |
Why?
|
| Epithelial Cells | 3 | 2014 | 3701 | 0.380 |
Why?
|
| Internationality | 1 | 2016 | 1008 | 0.360 |
Why?
|
| Myosin Type II | 2 | 2021 | 71 | 0.350 |
Why?
|
| Cell Migration Assays | 2 | 2012 | 22 | 0.350 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 812 | 0.350 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2014 | 755 | 0.340 |
Why?
|
| Signal Transduction | 15 | 2024 | 23652 | 0.340 |
Why?
|
| Brain | 6 | 2021 | 27476 | 0.330 |
Why?
|
| Cell Line | 13 | 2023 | 15603 | 0.330 |
Why?
|
| Single-Cell Analysis | 2 | 2018 | 2542 | 0.330 |
Why?
|
| T-Lymphocytes | 4 | 2015 | 10276 | 0.330 |
Why?
|
| Histones | 1 | 2020 | 2603 | 0.330 |
Why?
|
| Immunity, Innate | 7 | 2023 | 3080 | 0.330 |
Why?
|
| Cytokines | 8 | 2021 | 7453 | 0.330 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 697 | 0.320 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2024 | 892 | 0.320 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 1036 | 0.320 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 489 | 0.310 |
Why?
|
| Neurons | 7 | 2023 | 9524 | 0.310 |
Why?
|
| Serum | 1 | 2009 | 207 | 0.310 |
Why?
|
| Gene Expression Profiling | 7 | 2018 | 9549 | 0.310 |
Why?
|
| Electronics | 1 | 2009 | 317 | 0.300 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 2238 | 0.290 |
Why?
|
| Neoplasms | 7 | 2023 | 22390 | 0.290 |
Why?
|
| Ice | 3 | 2004 | 102 | 0.280 |
Why?
|
| Lipoxins | 3 | 2015 | 419 | 0.280 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1904 | 0.280 |
Why?
|
| Gene Expression | 3 | 2018 | 7602 | 0.280 |
Why?
|
| Animals | 46 | 2022 | 169408 | 0.280 |
Why?
|
| Leukocyte Count | 2 | 2018 | 1609 | 0.280 |
Why?
|
| Larva | 3 | 2017 | 514 | 0.270 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2008 | 340 | 0.270 |
Why?
|
| Rats | 8 | 2018 | 23847 | 0.270 |
Why?
|
| Cell Line, Tumor | 16 | 2024 | 17174 | 0.270 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 2149 | 0.270 |
Why?
|
| Microglia | 3 | 2019 | 1376 | 0.260 |
Why?
|
| Blood Preservation | 2 | 2017 | 169 | 0.260 |
Why?
|
| Cryoprotective Agents | 2 | 2021 | 128 | 0.260 |
Why?
|
| Leukotriene B4 | 3 | 2021 | 281 | 0.250 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 2736 | 0.250 |
Why?
|
| Exosomes | 1 | 2009 | 429 | 0.240 |
Why?
|
| Micromanipulation | 1 | 2005 | 53 | 0.240 |
Why?
|
| Systemic Inflammatory Response Syndrome | 4 | 2022 | 621 | 0.240 |
Why?
|
| Eukaryotic Cells | 1 | 2006 | 192 | 0.240 |
Why?
|
| Eicosapentaenoic Acid | 3 | 2015 | 565 | 0.230 |
Why?
|
| RNA | 5 | 2011 | 2727 | 0.230 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2011 | 749 | 0.230 |
Why?
|
| Membranes, Artificial | 1 | 2006 | 367 | 0.230 |
Why?
|
| Fibroblasts | 2 | 2014 | 4178 | 0.230 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 4356 | 0.220 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2024 | 257 | 0.220 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 2517 | 0.220 |
Why?
|
| Lipopolysaccharides | 2 | 2025 | 2222 | 0.210 |
Why?
|
| Cells | 1 | 2004 | 166 | 0.210 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2024 | 175 | 0.210 |
Why?
|
| Cell Size | 3 | 2018 | 626 | 0.210 |
Why?
|
| Cell-Derived Microparticles | 2 | 2016 | 161 | 0.210 |
Why?
|
| Skin | 5 | 2021 | 4507 | 0.210 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2022 | 28 | 0.210 |
Why?
|
| Blood Cell Count | 3 | 2019 | 406 | 0.210 |
Why?
|
| Candida | 2 | 2021 | 173 | 0.210 |
Why?
|
| Microarray Analysis | 2 | 2020 | 755 | 0.200 |
Why?
|
| Mitochondria | 2 | 2013 | 3683 | 0.200 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2021 | 30 | 0.200 |
Why?
|
| Basidiomycota | 1 | 2021 | 17 | 0.200 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 274 | 0.200 |
Why?
|
| Cell Aggregation | 3 | 2021 | 238 | 0.190 |
Why?
|
| Plaque, Amyloid | 2 | 2018 | 769 | 0.190 |
Why?
|
| P-Selectin | 3 | 2016 | 599 | 0.190 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 9 | 0.190 |
Why?
|
| Cell Culture Techniques | 4 | 2018 | 1667 | 0.190 |
Why?
|
| Staphylococcal Infections | 2 | 2022 | 1398 | 0.190 |
Why?
|
| Biological Phenomena | 1 | 2021 | 28 | 0.190 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2021 | 87 | 0.190 |
Why?
|
| Necrosis | 2 | 2018 | 1621 | 0.190 |
Why?
|
| Neoplastic Cells, Circulating | 5 | 2017 | 957 | 0.180 |
Why?
|
| Ascomycota | 1 | 2021 | 81 | 0.180 |
Why?
|
| Cell Polarity | 4 | 2021 | 639 | 0.180 |
Why?
|
| Complement C5 | 1 | 2021 | 104 | 0.180 |
Why?
|
| Neutrophil Activation | 1 | 2021 | 180 | 0.180 |
Why?
|
| Inflammation Mediators | 3 | 2016 | 1890 | 0.180 |
Why?
|
| Nanotechnology | 3 | 2012 | 714 | 0.180 |
Why?
|
| Nanostructures | 1 | 2006 | 553 | 0.180 |
Why?
|
| Microtubules | 3 | 2013 | 1062 | 0.180 |
Why?
|
| Tauopathies | 2 | 2018 | 328 | 0.180 |
Why?
|
| Green Fluorescent Proteins | 6 | 2018 | 2067 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2018 | 1073 | 0.180 |
Why?
|
| Interleukin-1beta | 2 | 2025 | 1027 | 0.170 |
Why?
|
| Cryoelectron Microscopy | 1 | 2004 | 649 | 0.170 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4624 | 0.170 |
Why?
|
| Freezing | 4 | 2009 | 311 | 0.170 |
Why?
|
| Stress, Mechanical | 2 | 2018 | 1680 | 0.170 |
Why?
|
| Complement C3 | 1 | 2021 | 434 | 0.170 |
Why?
|
| Organ Transplantation | 2 | 2021 | 1178 | 0.170 |
Why?
|
| Time Factors | 16 | 2016 | 40266 | 0.170 |
Why?
|
| Models, Theoretical | 6 | 2020 | 3580 | 0.160 |
Why?
|
| Helicobacter pylori | 1 | 2022 | 380 | 0.160 |
Why?
|
| Biosensing Techniques | 1 | 2005 | 662 | 0.150 |
Why?
|
| Stochastic Processes | 2 | 2010 | 360 | 0.150 |
Why?
|
| Toll-Like Receptors | 1 | 2022 | 582 | 0.150 |
Why?
|
| Coculture Techniques | 2 | 2021 | 1342 | 0.150 |
Why?
|
| Adenine | 1 | 2024 | 995 | 0.150 |
Why?
|
| Mouth | 1 | 2021 | 383 | 0.150 |
Why?
|
| Adult | 18 | 2025 | 223818 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2020 | 2475 | 0.150 |
Why?
|
| Mycoses | 1 | 2021 | 386 | 0.150 |
Why?
|
| Immunity | 2 | 2021 | 1003 | 0.150 |
Why?
|
| Leukocyte Elastase | 1 | 2018 | 114 | 0.150 |
Why?
|
| Neural Stem Cells | 2 | 2018 | 895 | 0.150 |
Why?
|
| Microtechnology | 1 | 2018 | 70 | 0.150 |
Why?
|
| Phenotype | 4 | 2024 | 16735 | 0.140 |
Why?
|
| Male | 30 | 2025 | 365249 | 0.140 |
Why?
|
| Critical Illness | 3 | 2018 | 2754 | 0.140 |
Why?
|
| Laboratory Animal Science | 1 | 2017 | 9 | 0.140 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 631 | 0.140 |
Why?
|
| Chromatin | 2 | 2022 | 2981 | 0.140 |
Why?
|
| Wound Healing | 4 | 2012 | 2815 | 0.140 |
Why?
|
| Cell Tracking | 1 | 2018 | 140 | 0.140 |
Why?
|
| Species Specificity | 1 | 2021 | 2419 | 0.140 |
Why?
|
| Length of Stay | 2 | 2025 | 6525 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2023 | 4940 | 0.140 |
Why?
|
| Glutamate Decarboxylase | 1 | 2018 | 239 | 0.140 |
Why?
|
| Molecular Chaperones | 2 | 2014 | 763 | 0.140 |
Why?
|
| Peroxidase | 1 | 2020 | 610 | 0.140 |
Why?
|
| Chemokine CXCL10 | 2 | 2015 | 312 | 0.140 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 370 | 0.140 |
Why?
|
| Pseudomonas Infections | 1 | 2021 | 623 | 0.140 |
Why?
|
| Neutropenia | 1 | 2022 | 893 | 0.140 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2021 | 1276 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2015 | 1813 | 0.130 |
Why?
|
| Mice | 24 | 2022 | 82074 | 0.130 |
Why?
|
| Ficoll | 1 | 2016 | 39 | 0.130 |
Why?
|
| Young Adult | 11 | 2021 | 60110 | 0.130 |
Why?
|
| Cell Survival | 5 | 2017 | 5794 | 0.130 |
Why?
|
| Silicones | 1 | 2017 | 228 | 0.130 |
Why?
|
| Succinimides | 1 | 2015 | 83 | 0.130 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2016 | 136 | 0.130 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 573 | 0.130 |
Why?
|
| Cell Adhesion | 4 | 2014 | 3102 | 0.130 |
Why?
|
| Piperidines | 1 | 2024 | 1669 | 0.120 |
Why?
|
| Biophysical Phenomena | 2 | 2009 | 320 | 0.120 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 214 | 0.120 |
Why?
|
| Median Eminence | 1 | 2014 | 28 | 0.120 |
Why?
|
| Prostaglandins | 1 | 2015 | 398 | 0.120 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2015 | 222 | 0.120 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 18366 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 587 | 0.120 |
Why?
|
| Liver Function Tests | 1 | 2016 | 526 | 0.120 |
Why?
|
| Cromolyn Sodium | 1 | 2014 | 78 | 0.120 |
Why?
|
| Confined Spaces | 1 | 2014 | 10 | 0.120 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 457 | 0.110 |
Why?
|
| Leukotrienes | 1 | 2015 | 232 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 7472 | 0.110 |
Why?
|
| Cyclic N-Oxides | 1 | 2014 | 72 | 0.110 |
Why?
|
| Cell Count | 2 | 2016 | 1833 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2016 | 4413 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1524 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2022 | 1181 | 0.110 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1161 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 1855 | 0.110 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 684 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2020 | 1356 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2018 | 1963 | 0.110 |
Why?
|
| Cell Nucleolus | 1 | 2014 | 156 | 0.110 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2013 | 279 | 0.110 |
Why?
|
| Cell Differentiation | 4 | 2021 | 11684 | 0.110 |
Why?
|
| Middle Aged | 13 | 2025 | 223740 | 0.110 |
Why?
|
| Microvessels | 2 | 2015 | 586 | 0.110 |
Why?
|
| Chemokines | 1 | 2018 | 963 | 0.110 |
Why?
|
| Female | 29 | 2025 | 397464 | 0.110 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 564 | 0.110 |
Why?
|
| Coloring Agents | 1 | 2016 | 564 | 0.110 |
Why?
|
| Homeostasis | 1 | 2024 | 3348 | 0.110 |
Why?
|
| Antigens | 2 | 2015 | 1444 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 1246 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1602 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 8664 | 0.100 |
Why?
|
| Pancreatic Elastase | 1 | 2012 | 125 | 0.100 |
Why?
|
| Hydrodynamics | 1 | 2013 | 167 | 0.100 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2012 | 56 | 0.100 |
Why?
|
| Dynamins | 1 | 2013 | 141 | 0.100 |
Why?
|
| Golgi Apparatus | 1 | 2014 | 407 | 0.100 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 905 | 0.100 |
Why?
|
| Microscopy, Phase-Contrast | 2 | 2009 | 110 | 0.100 |
Why?
|
| Spin Labels | 1 | 2014 | 339 | 0.100 |
Why?
|
| Laminin | 1 | 2014 | 406 | 0.100 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 793 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 5707 | 0.100 |
Why?
|
| Myosin Light Chains | 2 | 2022 | 122 | 0.100 |
Why?
|
| Anisotropy | 1 | 2015 | 1295 | 0.100 |
Why?
|
| Calibration | 2 | 2004 | 823 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1796 | 0.100 |
Why?
|
| Microchip Analytical Procedures | 1 | 2011 | 29 | 0.100 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2011 | 30 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 22381 | 0.100 |
Why?
|
| Biological Transport, Active | 1 | 2012 | 323 | 0.100 |
Why?
|
| Point-of-Care Systems | 2 | 2011 | 1240 | 0.100 |
Why?
|
| Random Allocation | 1 | 2016 | 2396 | 0.100 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 1295 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 865 | 0.090 |
Why?
|
| HIV Seropositivity | 2 | 2007 | 967 | 0.090 |
Why?
|
| Equipment Failure Analysis | 2 | 2016 | 848 | 0.090 |
Why?
|
| Mycobacterium smegmatis | 1 | 2011 | 126 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 9081 | 0.090 |
Why?
|
| Temperature | 4 | 2009 | 2235 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2007 | 2598 | 0.090 |
Why?
|
| Mice, Transgenic | 7 | 2021 | 9564 | 0.090 |
Why?
|
| Proteoglycans | 1 | 2014 | 809 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2010 | 203 | 0.090 |
Why?
|
| Pressure | 1 | 2013 | 1172 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1094 | 0.090 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 606 | 0.090 |
Why?
|
| Receptors, CXCR3 | 1 | 2011 | 240 | 0.090 |
Why?
|
| Thrombosis | 2 | 2016 | 2956 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 1962 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2018 | 2614 | 0.090 |
Why?
|
| Cell Migration Inhibition | 2 | 2008 | 97 | 0.090 |
Why?
|
| Particle Size | 3 | 2008 | 1652 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2018 | 2884 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 524 | 0.080 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2010 | 120 | 0.080 |
Why?
|